{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T17:38:04Z","timestamp":1706377084327},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,6,1]],"date-time":"1993-06-01T00:00:00Z","timestamp":738892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotherapy"],"published-print":{"date-parts":[[1993,6]]},"DOI":"10.1007\/bf01877426","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T16:43:36Z","timestamp":1120495416000},"page":"133-138","source":"Crossref","is-referenced-by-count":1,"title":["Effect of postoperative intrapleural instillations of interleukin-2 in patients with malignant pleurisy due to lung cancer"],"prefix":"10.1007","volume":"6","author":[{"given":"Kosei","family":"Yasumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Nakahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyoshi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Sugimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuo","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01877426_CR1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Leitman S, Change AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson CG, Reichert CM. Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485\u201392.","journal-title":"N Engl J Med"},{"key":"BF01877426_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00199837","volume":"24","author":"RL Kradin","year":"1987","unstructured":"Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT. Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 1987; 24:76\u201385.","journal-title":"Cancer Immunol Immunother"},{"key":"BF01877426_CR3","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.142.12.4520","volume":"142","author":"A Belldegrun","year":"1989","unstructured":"Belldegrun A, Kasid A, Uppenkamp M, Topalian SL, Rosenberg SA. Human tumor infiltrating lymphocytes; Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J Immunol 1989; 142:4520\u20136.","journal-title":"J Immunol"},{"key":"BF01877426_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jso.2930380404","volume":"38","author":"K Yasumoto","year":"1988","unstructured":"Yasumoto K, Takeo S, Yano T, Nakahashi H, Nagashima A, Sugimachi K, Nomoto K. Role of tumor infiltrating lymphocytes in host defence mechanisms against lung cancer. J Surg Oncol 1988; 38:221\u20136.","journal-title":"J Surg Oncol"},{"key":"BF01877426_CR5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4049\/jimmunol.136.5.1899","volume":"136","author":"S Miescher","year":"1986","unstructured":"Miescher S, Whiteside TL, Carrel S, von Fliedner W. Functional properties of tumor-inflicting and blood lymphocytes in patients with solid tumors; Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986; 136:1899\u2013907.","journal-title":"J Immunol"},{"key":"BF01877426_CR6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.138.3.989","volume":"138","author":"LM Mull","year":"1987","unstructured":"Mull LM, Spiess PJ, Director EP, Rosenberg SA. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 1987; 138:989\u201395.","journal-title":"J Immunol"},{"key":"BF01877426_CR7","first-page":"206","volume":"48","author":"A Belldegrun","year":"1988","unstructured":"Belldegrun A, Muul LM, Rosenberg SA. Interleukin-2-expanded tumor-infiltrating lymphocytes in human renal cell cancer; isolation, characterization, and antitumor activity. Cancer Res 1988; 48:206\u201314.","journal-title":"Cancer Res"},{"key":"BF01877426_CR8","first-page":"6353","volume":"47","author":"DS Heo","year":"1987","unstructured":"Heo DS, Whiteside TL, Johnson JT, Chen K, Barnes EL, Herberman RB. Long-term interleukin-2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck Cancer Res 1987; 47:6353\u201362.","journal-title":"Cancer Res"},{"key":"BF01877426_CR9","first-page":"2184","volume":"47","author":"K Yasumoto","year":"1987","unstructured":"Yasumoto K, Miyazaki K, Nagashima A, Ishida T, Kuda T, Yano T, Sugimachi K, Nomoto K. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Cancer Res 1987; 47:2184\u201387.","journal-title":"Cancer Res"},{"key":"BF01877426_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02221327","volume":"3","author":"K Yasumoto","year":"1991","unstructured":"Yasumoto K, Ogura T. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study. Biother 1991; 3:345\u20139.","journal-title":"Biother"},{"key":"BF01877426_CR11","first-page":"63","volume":"4","author":"MJ Mattews","year":"1973","unstructured":"Mattews MJ, Kanhouwa S, Pickren J, Robinette D. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection in lung cancer. Cancer Chemother Rep 1973; 4:63\u20137.","journal-title":"Cancer Chemother Rep"},{"key":"BF01877426_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jama.1966.03100170084026","volume":"4","author":"DL Paulson","year":"1966","unstructured":"Paulson DL. The survival rate in superior sulcus tumors treated by presurgical irradiation. JAMA 1966; 4:342.","journal-title":"JAMA"},{"key":"BF01877426_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-5223(19)39476-0","volume":"81","author":"MF McKneally","year":"1981","unstructured":"McKneally MF, Maver C, Lininger L, Kausel HW, McIlduff JB, Older TM, Foster ED, Alley RD. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer. J Thorac Cardiovasc Surg 1981; 81:485\u201392.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF01877426_CR14","first-page":"1413","volume":"45","author":"K Yasumoto","year":"1985","unstructured":"Yasumoto K, Yaita H, Ohta M, Azuma I, Nomoto K, Inokuchi K, Yamamura Y. Randomly controlled study of chemotherapy versus chemoimmunotherapy in post-operative lung cancer patients. Cancer Res 1985; 45:1413\u20137.","journal-title":"Cancer Res"},{"key":"BF01877426_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/1097-0142(1984)54:4<663::AID-CNCR2820540413>3.0.CO;2-2","volume":"54","author":"T Fujisawa","year":"1984","unstructured":"Fujisawa T, Yamaguchi Y, Kimura H, Arita M, Baba M, Shiba M. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer 1984; 54:663\u20139.","journal-title":"Cancer"},{"key":"BF01877426_CR16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.33.2.250","volume":"33","author":"FR Edwards","year":"1978","unstructured":"Edwards FR, Whitewell F. Use of BCG as an immuno-stimulant in the surgical treatment of immunostimulant in the surgical treatment of carcinoma of lung-a five year follow-up report. Thorax 1978; 33:250\u20132.","journal-title":"Thorax"},{"key":"BF01877426_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-5223(19)39259-1","volume":"82","author":"CF Mountain","year":"1981","unstructured":"Mountain CF, Gail MH. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. J Thorac Cardiovasc Surg 1981; 82:649\u201357.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF01877426_CR18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5223(19)38690-8","volume":"89","author":"Ludwig Lung Cancer Study Group","year":"1985","unstructured":"Ludwig Lung Cancer Study Group. Adverse effect of intrapleuralCorynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1985; 89:842\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF01877426_CR19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan DA, Ruscetti FW, Gallow R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (Wash DC) 1976; 193:1007\u20138.","journal-title":"Science (Wash DC)"},{"key":"BF01877426_CR20","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.121.6.2168","volume":"121","author":"PE Baker","year":"1982","unstructured":"Baker PE, Gillis S, Ferm MM, Smith KA. The effect of T cell growth factor on the generation of cytolytic T cells. J Immunol 1982; 121:2168\u201373.","journal-title":"J Immunol"},{"key":"BF01877426_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/291335a0","volume":"291","author":"CS Henney","year":"1981","unstructured":"Henney CS, Kuribayashi K, Kern DE, Gillis S. Interleukin-2 augments natural killer cell activity. Nature (Lond) 1981; 291:335\u20138.","journal-title":"Nature (Lond)"},{"key":"BF01877426_CR22","first-page":"4420","volume":"41","author":"MT Lotze","year":"1981","unstructured":"Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 1981; 41:4420\u20135.","journal-title":"Cancer Res"},{"key":"BF01877426_CR23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155:1823\u201341.","journal-title":"J Exp Med"},{"key":"BF01877426_CR24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","volume":"210","author":"SA Rosenberg","year":"1989","unstructured":"Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 1989; 210:474\u201385.","journal-title":"Ann Surg"},{"key":"BF01877426_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/bjc.1983.15","volume":"47","author":"C Bindon","year":"1983","unstructured":"Bindon C, Czerniecki M, Ruell P, Edwards A, McCarthy WH, Harris R, Hersey P. Clearance rates and systemic effects of intravenously administered interleukin-2 (IL-2) containing preparations in human subjects. Br J Cancer 1983; 47:123\u201333.","journal-title":"Br J Cancer"}],"container-title":["Biotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01877426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01877426\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01877426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T16:47:54Z","timestamp":1706374074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01877426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["BF01877426"],"URL":"https:\/\/doi.org\/10.1007\/bf01877426","relation":{},"ISSN":["0921-299X","1573-8280"],"issn-type":[{"value":"0921-299X","type":"print"},{"value":"1573-8280","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}